Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blue Jet HealthcareBOM:544009 -0.65%64 Pretax Margin % is 37.14% as of Mar. 2026, which is 5% above its 10-year median of 35.48. GuruFocus rates BOM:544009 with a GF Score™ of 64/100 and a GF Value™ of ₹562.05 (Fairly Valued). The stock has 10 warning signs investors should review. Among 942 Biotechnology companies, Blue Jet Healthcare ranks better than 92.04% on this metric.
The historical rank and industry rank for Blue Jet Healthcare's Pretax Margin % or its related term are showing as below:
BOM:544009'
s Pretax Margin % Range Over the Past 10 Years
Min: 30.06 Med: 35.48 Max: 39.43
Current: 35.1
BOM:544009's Pretax Margin % is ranked better than 92.04% of 942
companies
in the Biotechnology industry
Industry Median: -89.895
vs BOM:544009: 35.10
Blue Jet Healthcare (BOM:544009) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Blue Jet Healthcare Pretax Margin % Related Terms
Blue Jet Healthcare Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Blue Jet Healthcare's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544009 vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Blue Jet Healthcare's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blue Jet Healthcare Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Blue Jet Healthcare's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blue Jet Healthcare (BOM:544009) has a Pretax Margin % of 37.14% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Blue Jet Healthcare and its competitors. This is near median its historical median of 35.48. Over the past decade, Blue Jet Healthcare's Pretax Margin % has ranged from 30.06 to 39.43. According to the industry distribution chart, Blue Jet Healthcare ranks #75 out of 942 companies in the Biotechnology industry, placing it in the top 8%.
Is Blue Jet Healthcare's Pretax Margin % too high?
Blue Jet Healthcare's current Pretax Margin % of 37.14% is near median its 10-year median of 35.48. Over the past 10 years, this metric has ranged from a low of 30.06 to a high of 39.43. Based on the distribution chart, Blue Jet Healthcare ranks #75 out of 942 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Blue Jet Healthcare has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Blue Jet Healthcare ranks #75 out of 942 companies for Pretax Margin %. This places Blue Jet Healthcare in the top 8% of its industry — outperforming the majority of peers. Historically, Blue Jet Healthcare's own Pretax Margin % has ranged from 30.06 to 39.43 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Blue Jet Healthcare and its competitors. Blue Jet Healthcare's current Pretax Margin % is 37.14%, which is near median its own 10-year median of 35.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Fairly Valued. The stock's GF Value™ is ₹562.05, compared to a current price of ₹584.70 — trading 4% above its estimated fair value. The current Pretax Margin % is 37.14%, which is near median its 10-year median of 35.48. Blue Jet Healthcare's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current Pretax Margin % is 37.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?
Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued.
The current stock price of ₹584.70 is trading 4% above its estimated GF Value™ of ₹562.05.
GuruFocus considers Blue Jet Healthcare to be Fairly Valued.
Key valuation signals for BOM:544009:
Pretax Margin %: 37.14% (near median its 10-year median of 35.48)
GF Value™: ₹562.05 vs. price of ₹584.70 (4% above fair value)
No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
64GF Score
Get the complete analysis for BOM:544009
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544009 has been successfully added to your 
